BofA sees more upside in Eli Lilly stock

Summary

Eli Lilly’s first-quarter report gave Wall Street another reason to stay optimistic about one of the market’s biggest pharmaceutical winners, even as analys...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage